Meeting News

Dabrafenib-trametinib combination doubles RFS in resected stage III melanoma

September 11, 2017
MADRID — Adjuvant treatment with dabrafenib and trametinib doubled RFS compared with placebo among patients with resected stage III…

Meeting NewsPerspective

Nivolumab superior to ipilimumab for adjuvant treatment of surgically resected melanoma

September 11, 2017
MADRID — Adjuvant treatment with nivolumab significantly prolonged RFS compared with standard ipilimumab for patients with surgically resected…

FDA News

FDA grants breakthrough therapy designation to cemiplimab for advanced cutaneous squamous cell carcinoma

September 8, 2017
The FDA granted breakthrough therapy designation to cemiplimab for the treatment of adults with metastatic or locally advanced and unresectable…

In the Journals

Study identifies SNP, demographic factors associated with nonmelanoma skin cancer

September 1, 2017
The BsmI single-nucleotide polymorphism, along with several demographic factors, predicted nonmelanoma skin cancer risk, according to recent…

FDA News

FDA grants fast track designation to LN-144 for advanced melanoma

September 1, 2017
The FDA granted fast track designation to LN-144 for the treatment of advanced melanoma, according to the drug’s manufacturer. LN-144 (Iovance…

In the Journals

One-third of melanomas develop from preexisting nevus

August 30, 2017
Nevus-associated melanomas accounted for approximately one-third of all melanomas found in a recent systematic review and meta-analysis. Researchers…

FDA News

FDA grants breakthrough therapy designation to mogamulizumab for mycosis fungoides, Sézary syndrome

August 25, 2017
The FDA granted breakthrough therapy designation to mogamulizumab for the treatment of mycosis fungoides and Sézary syndrome, according to the…

In the Journals

BAP1 mutations may be associated with melanocytic tumors

August 25, 2017
Germline mutations in the BAP1 gene may be associated with melanocytic BAP1–mutated atypical intradermal tumors, according to recent findings…

In the Journals

Voriconazole may increase squamous cell carcinoma risk in hematopoietic transplant setting

August 21, 2017
Voriconazole was associated with a statistically significant increase in cutaneous squamous cell carcinoma risk in a cohort of individuals who…

In the Journals

Melanoma immunotherapy trials may not capture all toxicity data

August 17, 2017
Common Terminology Criteria for Adverse Events may not appropriately reflect immune-related adverse event severity, duration or timing, according to…

FDA News

FDA grants priority review to Adcetris for cutaneous T-cell lymphoma

August 16, 2017
The FDA granted priority review to brentuximab vedotin for the treatment of cutaneous T-cell lymphoma, according to the drug’s manufacturer…

In the Journals

Erivedge for basal cell carcinoma not associated with increased risk of subsequent SCC

August 10, 2017
There was no increased risk for subsequent squamous cell carcinoma associated with Erivedge treatment compared with standard treatment for patients…

In the Journals

Perineural invasion increased recurrence risk in cutaneous squamous cell carcinoma

August 9, 2017
Patients with perineural invasion in cutaneous squamous cell carcinoma were more likely to experience recurrence than patients without perineural…

In the Journals

Adequate adjuvant radiation therapy dose found for Merkel cell carcinoma

August 8, 2017
Patients with Merkel cell carcinoma experienced satisfactory overall survival results following an adjuvant radiation therapy dose ranging from 40 Gy…

In the Journals

Patients react positively to PCPs conducting skin cancer examination

August 2, 2017
Patients had a positive reaction to having a primary care physician conduct a clinical skin examination, according to recently published study…

Top five dermatology stories in July include psoriasis studies, FDA approval

July 31, 2017
Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the…

In the Journals

PDE5 inhibitors slightly increased melanoma, basal cell carcinoma risk

July 31, 2017
Phosphodiesterase type 5 inhibitors were associated with a moderate increase in risk for melanoma and basal cell carcinoma, but not squamous cell…

In the Journals

Dermatology consultation affects pediatric oncology patient care

July 28, 2017
Outpatient dermatology consultation changed the diagnosis and the management of disease in children with cancer, affecting their care, according to…

In the Journals

Renal transplant recipients at greater risk for melanoma

July 27, 2017
Renal transplant recipients had a greater risk than the general population for melanoma, according to recently published study results in JAMA

In the Journals

HIV infection associated with subsequent squamous cell carcinoma risk

July 26, 2017
Non-Hispanic white patients with HIV and a history of nonmelanoma skin cancer had a higher risk for subsequent new primary squamous cell carcinoma…

Healio Jobs